Patient Guide: A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 1 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06947499
Status: 🟢 Enrolling Now
Condition: Hepatitis A, Influenza, Human, Hepatitis B, Whooping Cough, Tetanus, Diphtheria, Poliomyelitis, Hepatitis, Tetany
Phase: PHASE2, PHASE3

Find a Study Location Near You

This study is available at 1 research site. We'll help you connect with the location that's right for you.

Participating sites include:
  • Dasmarinas, Cavite

Loading interactive enrollment tools...

The full interactive experience will load momentarily